Low-Density Lipoprotein Cholesterol Target Achievement Rates in Japanese Patients With Dyslipidemia ― Retrospective Analyses of a Nationwide Clinical Database ―

Background: Atherosclerotic cardiovascular disease (ASCVD) remains a major cause of mortality in Japan. The Japan Atherosclerosis Society (JAS) published revised guidelines in 2022 (JASGL2022), introducing updated low-density lipoprotein cholesterol (LDL-C) targets and patient criteria. Therefore, in this study, we assessed LDL-C target achievement among Japanese patients with dyslipidemia, as defined in the JASGL2022.